Combination drug therapy for low back pain
This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is to investigate the effects of combination drug therapy in reducing pain and disability in patients with low back pain and/or sciatica presenting to primary care, compared to mono drug therapy, no/minimal treatment or placebo. A secondary objective is to investigate combination drug tolerability, participants' rating of improvement and treatment satisfaction.
|Persistent URL||dx.doi.org/10.1002/14651858.CD011982, hdl.handle.net/1765/104548|
|Journal||Cochrane Database of Systematic Reviews|
Mathieson, S, Kasch, R. (Richard), Maher, C, Pinto, R.Z, McLachlan, A.J, Koes, B.W, & Lin, C.-W.C. (Chung-Wei Christine). (2015). Combination drug therapy for low back pain. Cochrane Database of Systematic Reviews, 2015(12). doi:10.1002/14651858.CD011982